全文获取类型
收费全文 | 8176篇 |
免费 | 359篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 201篇 |
儿科学 | 170篇 |
妇产科学 | 124篇 |
基础医学 | 1710篇 |
口腔科学 | 174篇 |
临床医学 | 535篇 |
内科学 | 1248篇 |
皮肤病学 | 477篇 |
神经病学 | 810篇 |
特种医学 | 291篇 |
外科学 | 1103篇 |
综合类 | 55篇 |
一般理论 | 3篇 |
预防医学 | 388篇 |
眼科学 | 194篇 |
药学 | 603篇 |
中国医学 | 24篇 |
肿瘤学 | 444篇 |
出版年
2022年 | 59篇 |
2021年 | 96篇 |
2020年 | 92篇 |
2019年 | 93篇 |
2018年 | 118篇 |
2017年 | 100篇 |
2016年 | 111篇 |
2015年 | 143篇 |
2014年 | 181篇 |
2013年 | 215篇 |
2012年 | 366篇 |
2011年 | 403篇 |
2010年 | 267篇 |
2009年 | 234篇 |
2008年 | 393篇 |
2007年 | 427篇 |
2006年 | 395篇 |
2005年 | 416篇 |
2004年 | 378篇 |
2003年 | 348篇 |
2002年 | 390篇 |
2001年 | 81篇 |
2000年 | 85篇 |
1999年 | 105篇 |
1998年 | 96篇 |
1997年 | 103篇 |
1996年 | 77篇 |
1995年 | 58篇 |
1994年 | 63篇 |
1993年 | 50篇 |
1992年 | 55篇 |
1991年 | 52篇 |
1989年 | 45篇 |
1988年 | 44篇 |
1987年 | 42篇 |
1985年 | 54篇 |
1982年 | 46篇 |
1940年 | 45篇 |
1939年 | 58篇 |
1938年 | 54篇 |
1937年 | 43篇 |
1932年 | 48篇 |
1930年 | 48篇 |
1928年 | 58篇 |
1927年 | 48篇 |
1926年 | 49篇 |
1925年 | 45篇 |
1923年 | 41篇 |
1922年 | 42篇 |
1913年 | 49篇 |
排序方式: 共有8554条查询结果,搜索用时 15 毫秒
1.
Michels Guido Horn Rudolf Helfen Andreas Hagendorff Andreas Jung Christian Hoffmann Beatrice Jaspers Natalie Kinkel Horst Greim Clemens-Alexander Knebel Fabian Bauersachs Johann Busch Hans-Jörg Kiefl Daniel Spiel Alexander O. Marx Gernot Dietrich Christoph F. 《Der Anaesthesist》2022,71(4):307-310
Die Anaesthesiologie - 相似文献
2.
Julie A. Schmidt Georgina K. Fensom Sabina Rinaldi Augustin Scalbert Paul N. Appleby David Achaintre Audrey Gicquiau Marc J. Gunter Pietro Ferrari Rudolf Kaaks Tilman Kühn Heiner Boeing Antonia Trichopoulou Anna Karakatsani Eleni Peppa Domenico Palli Sabina Sieri Rosario Tumino Bas Bueno-de-Mesquita Antonio Agudo Maria-Jose Sánchez María-Dolores Chirlaque Eva Ardanaz Nerea Larrañaga Aurora Perez-Cornago Nada Assi Elio Riboli Konstantinos K. Tsilidis Timothy J. Key Ruth C. Travis 《International journal of cancer. Journal international du cancer》2020,146(3):720-730
Metabolomics may reveal novel insights into the etiology of prostate cancer, for which few risk factors are established. We investigated the association between patterns in baseline plasma metabolite profile and subsequent prostate cancer risk, using data from 3,057 matched case–control sets from the European Prospective Investigation into Cancer and Nutrition (EPIC). We measured 119 metabolite concentrations in plasma samples, collected on average 9.4 years before diagnosis, by mass spectrometry (AbsoluteIDQ p180 Kit, Biocrates Life Sciences AG). Metabolite patterns were identified using treelet transform, a statistical method for identification of groups of correlated metabolites. Associations of metabolite patterns with prostate cancer risk (OR1SD) were estimated by conditional logistic regression. Supplementary analyses were conducted for metabolite patterns derived using principal component analysis and for individual metabolites. Men with metabolite profiles characterized by higher concentrations of either phosphatidylcholines or hydroxysphingomyelins (OR1SD = 0.77, 95% confidence interval 0.66–0.89), acylcarnitines C18:1 and C18:2, glutamate, ornithine and taurine (OR1SD = 0.72, 0.57–0.90), or lysophosphatidylcholines (OR1SD = 0.81, 0.69–0.95) had lower risk of advanced stage prostate cancer at diagnosis, with no evidence of heterogeneity by follow-up time. Similar associations were observed for the two former patterns with aggressive disease risk (the more aggressive subset of advanced stage), while the latter pattern was inversely related to risk of prostate cancer death (OR1SD = 0.77, 0.61–0.96). No associations were observed for prostate cancer overall or less aggressive tumor subtypes. In conclusion, metabolite patterns may be related to lower risk of more aggressive prostate tumors and prostate cancer death, and might be relevant to etiology of advanced stage prostate cancer. 相似文献
3.
4.
Johannes Woitzik Elke Lassel Ulf C. Schneider Helmut Schroeck Rudolf Graf 《Experimental neurology》2009,218(1):41-350
Lesion evolution during focal cerebral ischemia may depend on flow restrictions or on accumulation of toxic mediators within the infarct and expansion of these factors to the periinfarct region. So far, the precise contribution of flow dependent versus spreading-mediated impairment of viable periinfarct tissue has not been determined. Therefore, we measured lesion expansion, flow restrictions and glutamate distribution on serial brain sections at different time points after experimental focal ischemia.Permanent focal ischemia was induced by occlusion of the right middle cerebral artery in male rats and the flow reduction was subsequently measured at 1, 12 and 24 h using iodo[14C]antipyrine autoradiography. Additionally, the necrotic volume was determined on serial brain sections and the glutamate content was measured in tissue samples from adjacent microdissections.Twelve hours after focal ischemia no noteworthy viable areas with blood flow restrictions of 20-40 ml 100 g− 1 min− 1 existed but at 24 h the necrotic tissue exceeded the hemodynamically compromised region by 40 ± 21 mm3 (24%). Furthermore, at 12 and 24 h the glutamate content was elevated in areas surrounding the infarct.Relevant flow restrictions are detectable only during early stages of infarct maturation, whereas the propagation of secondary factors may be the predominant mechanism for delayed infarct evolution. 相似文献
5.
6.
7.
8.
Does Additional Doxorubicin Chemotherapy Improve Outcome in Patients with Hepatocellular Carcinoma Treated by Liver Transplantation? 总被引:5,自引:0,他引:5
Herwig Pokorny Michael Gnant Susanne Rasoul-Rockenschaub Bernd Gollackner Birgit Steiner Günter Steger Rudolf Steininger Ferdinand Mühlbacher 《American journal of transplantation》2005,5(4):788-794
The aim of this prospective randomized study was to determine whether additional doxorubicin chemotherapy improves outcome in patients with hepatocellular carcinoma (HCCA) treated by liver transplantation. Stratification parameters were tumor stage (UICC I-IVa), gender, age 50 years, α-fetoprotein 20 ng/mL, cirrhosis and HbsAg status. For pre-operative chemotherapy doxorubicin (15 mg/m2 ) was given biweekly, intra-operative chemotherapy was a single dose administered before surgical manipulation. Post-operative chemotherapy from day 10 was as given preoperatively for a total dosage of 300 mg/m2 . Outcome parameters were overall survival (OS) and disease-free survival. Of the 75 consecutive patients who received liver transplantation for treatment of HCCA, 62 patients were enrolled. Thirty-four patients were randomized in the chemotherapy group; 28 patients were in the control group and transplanted only. OS rates at 5 years were 38% in the chemotherapy group and 40% in the control group, disease-free survival rates at 5 years 43% and 53%, respectively. Tumor stage and vascular invasion were identified as independent risk factors for recurrence of disease. Doxorubicin chemotherapy did not improve organ survival and disease-free survival in patients undergoing liver transplantation for HCCA. 相似文献
9.
Qiang Tan Rudolf Steiner Simon P Hoerstrup Walter Weder 《European journal of cardio-thoracic surgery》2006,30(5):782-786
This review tries to summarize the efforts over the past 20 years to construct a tissue-engineered trachea. After illustrating the main technical bottlenecks faced nowadays, we discuss what might be the solutions to these bottlenecks. You may find out why the focus in this research field shifts dramatically from the construction of a tubular cartilage tissue to reepithelialization and revascularization of the prosthesis. In the end we propose a novel concept of 'in vivo bioreactor', defined as the design of a perfusion system inside the scaffold, and explain its potential application in the construction of a tissue-engineered trachea. 相似文献
10.
Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression 总被引:2,自引:0,他引:2
R. Bottlender Daniel Rudolf Anton Strauss Hans-Jürgen Möller 《European archives of psychiatry and clinical neuroscience》1998,248(6):296-300
Medical records of 158 patients with bipolar depression were analysed for the incidence of a switch from depression to maniform
states (mania and hypomania). Relation to psychopharmacological treatment was investigated. Thirty-nine (25%) patients of
the total sample had switched to a maniform state during the treatment period in the hospital. Among that group the phenomenon
occurred in 23 patients (15%) as a hypomania and in 16 patients (10%) as a mania. Patients with a switch were significantly
more often treated with tricyclic antidepressants (TCA) than patients without switch (79.5% vs 51.3%). Mood stabilising medication
might reduce the risk for switching, especially in patients treated with TCA; however, it seems not totally sufficient, since
59% of the switched patients received mood stabilisers. The switch phenomenon was not associated with sociodemographic or
clinical data.
Received: 23 September 1998 / Accepted: 28 September 1998 相似文献